CBD and THC have something in common: they originate from the hemp plant. Both are for that reason cannabinoids, that is to say active chemical compounds which act upon the body’s receptors (nervous system, organs, immune system, and so on). But they are likewise opposed on lots of points. Due to the fact that, unlike tetrahydrocannabinol (THC), cannabidiol (better CBD) does not make “stone” and does not represent any health hazard. Detailed evaluation.

CBD and THC: what differences?

Marijuana is an intricate product, comprised of a number of hundred particles – the “cannabinoids” – all with their particular residential or commercial properties The most famous is THC, for tetrahydrocannabinol, the active compound known for its psychotropic impacts. THC is what helps alter the consumer’s state of awareness, making them “high” or, as they say, making them “hover”. Simply put, when we talk about leisure marijuana use, it is usually a product abundant in THC that we refer to.

THC should not be confused with CBD. Cannabidiol is another particle in marijuana, but it does not have exactly the same function. Although it likewise has a sedative result, it works against THC to restrict its residential or commercial properties, in particular by relaxing the nervous system. At a specific rate, CBD makes it possible to delay the impacts of THC and to increase them significantly, but by limiting the dangers of “bad trip” (stress and anxiety and stress and anxiety often created by the intake of THC). Simply put, CBD has no psychotropic impacts. It does not make “stone”.

CBD: therapeutic residential or commercial properties.

It can be inferred from the above that the difference between composite CBD and THC does not lie just in the impacts produced by the 2 compounds. It mainly connects to the consequences on health. While THC is still considered a drug (even a moderate one) in a lot of countries, due to its psychoactive impacts, its propensity to be addicting, and more usually the dangers it positions to the body, it is quite the opposite with regard to CBD.

Cannabidiol is stated to have significant therapeutic residential or commercial properties. The prospective appears massive to say the least. Due to the fact that CBD would have analgesic and anti-inflammatory residential or commercial properties, would fight stress and anxiety and depression, relax the signs of epilepsy and multiple sclerosis, act versus particular psychotic conditions (such as schizophrenia), and so on, among other positive impacts. Some studies even recommend that at high concentrations, CBD serves as an inhibitor in the proliferation of tumor cells from particular cancers, and that it minimizes the risk of necrosis of the arteries after a cardiovascular disease.

Research in this area is simply starting, but the potential customers are enormous.

Legal CBD, unlawful THC

Another weight difference between CBD and THC: studies carried out to date tend to reveal that CBD is not addicting and is not hazardous, unlike THC. For this reason, it is not categorized in the category of managed compounds, and its sale is authorized in France in the liquid kind, planned for electronic cigarettes (see on this subject our article on the legality of CBD).

As such, cannabidiol-based products with a THC level of less than 0.2% are authorized for marketing. But there is no question of highlighting the differences between CBD and THC, nor of touting the therapeutic benefits of the previous. In France, cannabidiol can not be considered as a medication, and should stay what it is formally: a food supplement. But a supplement that does fantastic helpful for suffering individuals!

Scroll to top